06.01.2013 Views

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(C12N) I.1(1)<br />

• PRODUCTION OF PRODUCTS OF PHAR-<br />

MACEUTICAL INTEREST IN PLANT CELL<br />

CULTURES<br />

• PRODUCTION DE PRODUITS PRÉSEN-<br />

TANT UN INTÉRÊT PHARMACEUTIQUE<br />

DANS DES CULTURES DE CELLULES<br />

VÉGÉTALES<br />

(71) Dow Agrosciences LLC, <strong>Patent</strong> Counsel 9330<br />

Zionsville Rd., Indianapolis, IN 46268-1054,<br />

US<br />

(72) AINLEY, William, M., Carmel Indiana 46032,<br />

US<br />

WEBB, Steven, R., Westfield IN 46074, US<br />

LINDENBAUM, Michael, Beaconsfield Québec<br />

H9W 5G9, CA<br />

FABIJANSKI, Steven, F., Orleans Ontario K1C<br />

5N4, CA<br />

FU, Ping, Saskatoon Saskatchewan S7N<br />

4M5, CA<br />

MARILLIA, Elizabeth-France, Asquith Saskatchewan<br />

S0K 0J0, CA<br />

(74) Gerbino, Angelo, et al, Jacobacci & Partners<br />

S.p.A. Corso Emilia 8, 10152 Torino, IT<br />

C12N 5/10 → (51) A61K <strong>31</strong>/7105<br />

C12N 5/10 → (51) C07K 14/705<br />

C12N 5/10 → (51) C12N 15/63<br />

C12N 5/10 → (51) C12N 15/86<br />

C12N 5/10 → (51) C12N 15/88<br />

C12N 5/14 → (51) C12N 15/29<br />

(51) C12N 7/00 (11) 2 350 268 A1*<br />

C12M 3/06 C12N 15/861<br />

(25) En (26) En<br />

(21) 09744140.6 (22) 29.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA RS<br />

(86) EP 2009/064265 29.10.2009<br />

(87) WO 2010/060719 2010/22 03.06.2010<br />

(30) 03.11.2008 US 198122 P<br />

03.11.2008 EP 08168181<br />

(54) • VERFAHREN ZUR HERSTELLUNG VON<br />

ADENOVIRUSVEKTOREN<br />

• METHOD FOR THE PRODUCTION OF<br />

ADENOVIRAL VECTORS<br />

• PROCÉDÉ POUR LA PRODUCTION DE<br />

VECTEURS ADÉNOVIRAUX<br />

(71) Crucell Holland B.V., Archimedesweg 4,<br />

2333 CN Leiden, NL<br />

(72) LUITJENS, Alfred, NL-2333 CN Leiden, NL<br />

LEWIS, John Alfred, Little Compton Rhode<br />

Island 02837, US<br />

(74) Verhage, Richard Abraham, Crucell Holland<br />

B.V. IP Department Archimedesweg 4-6,<br />

2333 CN Leiden, NL<br />

(51) C12N 7/00 (11) 2 350 269 A1*<br />

C12N 7/01<br />

(25) En (26) En<br />

(21) 09824127.6 (22) 29.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/062548 29.10.2009<br />

(87) WO 2010/051367 2010/18 06.05.2010<br />

(30) <strong>31</strong>.10.2008 US 109958 P<br />

<strong>31</strong>.10.2008 US 109979 P<br />

<strong>31</strong>.10.2008 US 110028 P<br />

<strong>31</strong>.10.2008 US 109986 P<br />

<strong>31</strong>.10.2008 US 109957 P<br />

<strong>31</strong>.10.2008 US 109955 P<br />

<strong>31</strong>.10.2008 US 109997 P<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) • SIMIAN-ADENOVIREN SADV-43, -45, -48,<br />

-49 UND -50 SOWIE IHRE ANWENDUNG<br />

• SIMIAN ADENOVIRUSES SADV-43, -45,-<br />

48,-49, AND -50 AND USES THEREOF<br />

• ADÉNOVIRUS SIMIENS SADV-43, -45, -48,<br />

-49 ET 50 ET LEURS UTILISATIONS<br />

(71) The Trustees Of The University Of Pennsylvania,<br />

<strong>31</strong>60 Chestnut Street Suite 200,<br />

Philadelphia, PA 19104, US<br />

(72) ROY, Soumitra, Wayne PA 19087, US<br />

WILSON, James, M., Gladwyne PA 19035,<br />

US<br />

VANDENBERGHE, Luc, H., Philadelphia PA<br />

19146, US<br />

(74) Manaton, Ross Timothy, Bromhead Johnson<br />

19 Buckingham Street, London WC2 6EF, GB<br />

(51) C12N 7/01 (11) 2 350 270 A2*<br />

C12N 15/40 C07K 14/08<br />

C07K 16/10 G01N 33/68<br />

A61K 39/12<br />

(25) En (26) En<br />

(21) 09822840.6 (22) 26.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/062079 26.10.2009<br />

(87) WO 2010/048615 2010/17 29.04.2010<br />

(88) 25.11.2010<br />

(30) 24.10.2008 US 108175 P<br />

(54) • MENSCHLICHE EBOLAVIRUS-SPEZIES<br />

SOWIE ZUSAMMENSETZUNGEN UND<br />

VERFAHREN DAFÜR<br />

• HUMAN EBOLA VIRUS SPECIES AND<br />

COMPOSITIONS AND METHODS THEREOF<br />

• ESPÈCE DE VIRUS EBOLA HUMAIN ET<br />

COMPOSITIONS ET PROCÉDÉS ASSOCIÉS<br />

(71) The Government of the United States of<br />

America, as represented by the Secretary,<br />

Department of Health & Human Services,<br />

Centers for Disease Control and Prevention<br />

Technology Transfer <strong>Office</strong> 4770 Buford<br />

Highway MS K79, Atlanta, Georgia 30341,<br />

US<br />

(72) TOWNER, Jonathan, S., Atlanta, GA 30333,<br />

US<br />

NICHOL,Stuart, T., Atlanta, GA 30333, US<br />

COMER, James, A., Atlanta, GA 30333, US<br />

KSIAZEK, Thomas, G., Atlanta, GA 30333,<br />

US<br />

ROLLIN, Pierre, E., Atlanta, GA 30333, US<br />

(74) Alconada Rodríguez, Agustín, ABG <strong>Patent</strong>es<br />

S.L. Avenida de Burgos 16D Edificio Euromor,<br />

28036 Madrid, ES<br />

C12N 7/01 → (51) C12N 7/00<br />

(51) C12N 7/06 (11) 2 350 271 A1*<br />

(25) En (26) En<br />

(21) 09761053.9 (22) 20.11.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/006221 20.11.2009<br />

(87) WO 2010/059232 2010/21 27.05.2010<br />

(30) 20.11.2008 US 116534 P<br />

(54) • ARGININ-INAKTIVIERUNG VON VIREN<br />

• ARGININE INACTIVATION OF VIRUSES<br />

• INACTIVATION DE VIRUS PAR L'ARGI-<br />

NINE<br />

(71) Biogen Idec MA Inc., 14 Cambridge Center,<br />

Cambridge, MA 02142, US<br />

(72) SELVITELLI, Keith, Concord,MA 01742, US<br />

MCCUE, Justin, Cambridge,MA 02141, US<br />

(74) Miller, David James, et al, Mathys & Squire<br />

LLP 120 Holborn, London EC1N 2SQ, GB<br />

C12N 9/02 → (51) A61K 38/44<br />

215<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>31</strong>/<strong>2011</strong>) 03.08.<strong>2011</strong><br />

C12N 9/02 → (51) C25B 1/02<br />

C12N 9/04 → (51) C12P 7/16<br />

C12N 9/10 → (51) A61K 38/44<br />

C12N 9/10 → (51) C07K 14/395<br />

C12N 9/10 → (51) C12N 15/82<br />

C12N 9/12 → (51) C12N 15/85<br />

C12N 9/12 → (51) C12P 7/16<br />

C12N 9/18 → (51) C12P 7/16<br />

C12N 9/24 → (51) C12N 15/82<br />

C12N 9/36 → (51) C07K 7/08<br />

(51) C12N 9/42 (11) 2 350 272 A1*<br />

C12N 1/15 C12N 15/09<br />

C07K 14/37 C12N 15/80<br />

(25) En (26) En<br />

(21) 09828479.7 (22) 03.11.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) CA 2009/001590 03.11.2009<br />

(87) WO 2010/060188 2010/22 03.06.2010<br />

(30) 03.11.2008 US 110732 P<br />

(54) • WIRTE UND FERMENTIERUNGSVERFAH-<br />

REN ZUR ZELLULASEHERSTELLUNG<br />

• HOSTS AND FERMENTATION PROCESSES<br />

FOR CELLULASE PRODUCTION<br />

• HÔTES ET PROCÉDÉS DE FERMENTATION<br />

POUR LA PRODUCTION DE CELLULASES<br />

(71) Iogen Energy Corporation, <strong>31</strong>0 Hunt Club<br />

Road East, Ottawa, Ontario K1V 1C1, CA<br />

(72) GUDYNAITE-SAVITCH, Loreta, Kanata<br />

Ontario K2M 1N9, CA<br />

HINDLE, Christopher, D., Gloucester Ontario<br />

K1V 1L3, CA<br />

WHITE, Theresa, C., Ottawa Ontario K1V<br />

0W6, CA<br />

(74) Baldock, Sharon Claire, Boult Wade Tennant<br />

Verulam Gardens 70 Gray's Inn Road,<br />

London WC1X 8BT, GB<br />

(51) C12N 9/50 (11) 2 350 273 A2*<br />

C12N 15/57 C07K 19/00<br />

C12N 15/62 A61K 38/48<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 09824219.1 (22) 02.11.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/062969 02.11.2009<br />

(87) WO 2010/051533 2010/18 06.05.2010<br />

(88) 19.08.2010<br />

(30) <strong>31</strong>.10.2008 US 110218 P<br />

(54) • ZUSAMMENSETZUNGEN AUS MANIPU-<br />

LIERTEN MENSCHLICHEN ARGINASEN<br />

UND VERFAHREN ZUR BEHANDLUNG<br />

VON KREBS<br />

• COMPOSITIONS OF ENGINEERED HUMAN<br />

ARGINASES AND METHODS FOR TREAT-<br />

ING CANCER<br />

• COMPOSITIONS D'ARGINASES HUMAI-<br />

NES GÉNÉTIQUEMENT MODIFIÉES ET<br />

MÉTHODES POUR TRAITER LE CANCER<br />

(71) The Board of Regents of The University of<br />

Texas System, 201 West 7th Street, Austin,<br />

TX 78701, US<br />

(72) GEORGIOU, George, Austin, TX 787<strong>31</strong>, US<br />

STONE, Everett, Austin, TX 78752, US

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!